The global omega-3 market is on a strong growth trajectory, projected to expand from USD 4.36 billion in 2025 to USD 7.76 billion by 2030, registering a CAGR of 12.2% during the forecast period. As consumers increasingly prioritize nutrition and preventive health, omega-3 fatty acids—renowned for their benefits to heart, brain, and joint health—are becoming essential components in dietary supplements and functional foods.
Driving Forces Behind the Omega-3 Market Growth
The surge in omega-3 demands stems from growing consumer awareness about its numerous health benefits. Omega-3 fatty acids, particularly EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), play a crucial role in supporting cardiovascular wellness, enhancing cognitive function, and maintaining joint flexibility.
Additionally, the rising prevalence of chronic diseases, such as heart disorders, arthritis, and cognitive decline, has encouraged consumers to integrate omega-3-rich products into their diets. Omega-3s are increasingly viewed not just as nutritional supplements but as preventive and therapeutic agents for long-term health management.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227
Omega-3 Market Insights: Key Takeaways
By Source
Marine sources dominate the omega-3 market due to their higher concentrations of EPA and DHA, which are readily absorbed by the body. Fish oil, krill oil, and algal oil continue to lead the market thanks to their superior bioavailability and nutrient-rich profiles. These sources also offer complementary nutrients such as proteins, vitamins, and minerals, boosting their appeal among health-conscious consumers.
By Type
DHA is expected to hold the largest share of the omega-3 market, given its critical role in brain development and cognitive health. It is especially vital for prenatal nutrition and infant development, supported by strong scientific evidence and endorsements from global health organizations.
By Application
The dietary supplements segment continues to dominate, offering consumers an extensive range of product formats—including softgels, capsules, gummies, and liquids. This variety enables manufacturers to cater to evolving consumer lifestyles and preferences, promoting consistent market expansion.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227
Regional Outlook: Asia Pacific Leading the Charge
The Asia Pacific region is anticipated to witness the fastest growth in the omega-3 market through 2030. Rising disposable incomes, an aging population, and increasing investment in health and wellness are key growth drivers. Consumers across China, Japan, India, and Australia are becoming more aware of the preventive benefits of omega-3s for heart, brain, and joint health.
Furthermore, the infant nutrition segment is rapidly expanding as parents seek premium formulas fortified with DHA for early brain development. Government health initiatives and demographic shifts are creating a supportive environment for omega-3 market growth.
Innovations are also shaping regional dynamics, with growing demand for plant- and algae-based omega-3s driven by sustainability and veganism trends. Manufacturers are leveraging microencapsulation technologies to enhance product taste and stability, while diversification into functional foods, beverages, animal feed, pharmaceuticals, and clinical nutrition is unlocking new opportunities.
Leading Omega-3 Companies:
Leading companies are continuously investing in R&D, sustainable sourcing, and product innovation to strengthen their market position. Major players include:
- BASF SE (Germany)
- Cargill, Incorporated (US)
- dsm-firmenich (Netherlands)
- ADM (US)
- Kerry Group plc (Ireland)
- Aker BioMarine (Norway)
- Croda International plc (UK)
- Corbion (Netherlands)
- Pelagia AS (Norway)
- KD Pharma Group SA (Switzerland)
- GC Rieber (Norway)
- Cooke Aquaculture Inc. (Canada)
- GOLDEN OMEGA (Chile)
- Polaris (France)
- Btsa (Spain)
- KinOmega Biopharm Inc. (China)
- Rimfrost AS (Norway)
- Mara Renewables (Canada)
- Cellana Inc. (US)
- AlgaeCytes Limited (UK)
These companies are focusing on sustainability, improved bioavailability, and innovative delivery formats to meet evolving consumer demands.